Results 11 to 20 of about 4,991,692 (213)
Is it Vogt-Koyanagi-Harada syndrome?
Medical Journal of Dr. D.Y. Patil University, 2015 Vogt-Koyanagi-Harada syndrome (VKH syndrome) is named after ophthalmologists Alfred Vogt from Switzerland and Yoshizo Koyanagi and Einosuke Harada from Japan.
Digambar Dashatwar +2 more
doaj +2 more sources
Echographic findings in the late stages of Vogt-Koyanagi-Harada disease in mexican population
Revista Brasileira de Oftalmologia, 2014 Purpose: To correlate clinical findings of Vogt-Koyanagi-Harada disease with standardized echography findings in a cross-sectional, descriptive and observational study.
Mariana Mayorquín-Ruiz +4 more
doaj +2 more sources
Vogt-Koyanagi-Harada disease, a rare entity in Spain: the challenge of worldwide immigration and globalization [PDF]
European Journal of Case Reports in Internal Medicine, 2018 Vogt–Koyanagi–Harada disease is rare, mediated by autoimmune melanocyte inflammation and facilitated by genetic predisposition[1-3]. The main clinical features include uveitis, meningitis, tinnitus and sensorineural deafness, and skin and hair ...
Alberto Benavente Fernández +3 more
doaj +2 more sources
A Case of Probable Vogt-Koyanagi-Harada Disease
Türk Oftalmoloji Dergisi, 2012 The aim of this article is to present a rare form of Vogt-Koyanagi-Harada (VKH) disease. The complete and incomplete forms of VKH disease are more frequent than the probable form.
Mutlu Acar +3 more
doaj +2 more sources
Atypical presentation of acute retinal necrosis mimicking Vogt-Koyanagi-Harada disease leading to misdiagnosis: a case report [PDF]
Frontiers in MedicineAcute retinal necrosis (ARN) is a serious, sight-threatening condition characterized by rapidly progressive necrotizing retinitis, most commonly caused by varicella-zoster virus and herpes simplex virus. We report an atypical case of ARN in a 57-year-old
Wei Zhu +4 more
doaj +2 more sources
Classification criteria for Vogt-Koyanagi-Harada Disease
American journal of ophthalmology-glaucoma, 2021 Purpose: To determine classification criteria for Vogt-Koyanagi-Harada (VKH) disease Design: Machine learning of cases with VKH disease and 5 other panuveitides.
D. Jabs +11 more
semanticscholar +1 more source
Human Vaccines & Immunotherapeutics, 2023 Vogt-Koyanagi-Harada (VKH) disease is a rare and serious ocular adverse reaction following COVID-19 vaccination. This study aimed to evaluate the clinical features, diagnosis and management of COVID-19 vaccine-associated VKH disease.
Kevin J. Xu +5 more
semanticscholar +1 more source
Journal of Ophthalmic Inflammation and Infection, 2021 Vogt-Koyanagi-Harada (VKH) disease is a primary stromal choroiditis with bilateral granulomatous panuveitis. If initial-onset VKH is treated early and relentlessly the disease can be controlled and even “cured” in a substantial number of cases.
I. Papasavvas, C. Herbort
semanticscholar +1 more source
Journal of Ophthalmic Inflammation and Infection, 2022 Background Appraisals of Vogt-Koyanagi-Harada disease (VKH) have become progressively more complete, since its first description in 1906. The availability of new investigational methods has improved our knowledge of the immunopathology, clinicopathology,
Cristhian A. Urzua +7 more
semanticscholar +1 more source
Vogt-Koyanagi-Harada disease. [PDF]
, 2019 Vogt-Koyanagi-Harada disease is a rare, multisystem, autoimmune disorder with numerous clinical manifestations, mediated through a T-helper 1 response against melanocytes in the eye, inner ear, central nervous system, hair and skin. We describe a 20-year-
Mollan, Susan P +3 more
core +2 more sources